QualCert Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics)

The QualCert Level 7 Postgraduate Diploma in Pharmacoeconomics (PgD Pharmacoeconomics) is an advanced postgraduate program designed to equip pharmacists, healthcare professionals, and biomedical scientists with the specialized knowledge and analytical skills required to evaluate the economic impact of medicines and healthcare interventions. This diploma responds to the increasing global demand for professionals who can assess value, optimize resource allocation, and contribute to evidence‑based decision‑making in healthcare.

Learners will gain a comprehensive understanding of cost‑effectiveness analysis, health technology assessment (HTA), budget impact modeling, and outcome measurement. The program emphasizes practical application, enabling participants to critically evaluate pharmaceutical interventions, interpret economic data, and provide recommendations that balance clinical benefits with financial sustainability. Ethical considerations, patient access, and global healthcare priorities are embedded throughout the curriculum, ensuring graduates are prepared to address the challenges of modern healthcare delivery.

Participants will develop the ability to contribute to policy development, support reimbursement decisions, and guide pharmaceutical innovation through economic evaluation. Graduates will be prepared for specialist roles in pharmaceutical companies, health insurance organizations, government agencies, hospital management, and academia. By concentrating exclusively on pharmacoeconomics, the program ensures learners acquire specialized expertise that positions them as leaders in shaping healthcare systems that are both clinically effective and economically sustainable.

Course Overview

Awarding Body

QualCert

Credits

120 Credits

Study Mood

Online

Assessment

Assignments Based

Course Study Units

Principles of Pharmacoeconomics
Health Technology Assessment (HTA)
Budget Impact and Resource Allocation
Advanced Economic Modelling
Research Methodologies and Evidence-Based Pharmacoeconomics
Policy, Governance, and Pharmaceutical Strategy

Entry Requirements

Minimum age: Minimum age of 21 years.
Educational background: A recognized degree in pharmacy, pharmaceutical sciences, medicine, biomedical sciences, health economics, or a related discipline is required.
Language proficiency: English language proficiency is required to ensure full participation in coursework and assessments.
Work experience: Relevant professional or industry experience in healthcare, pharmaceutical practice, health economics, or policy analysis is expected.

Who Can Enroll

This diploma is designed for professionals aiming to specialize in pharmacoeconomics and healthcare decision‑making.

Pharmacists, healthcare professionals, biomedical scientists, or policy analysts
Interest in health economics, cost‑effectiveness analysis, and healthcare resource allocation
Background in pharmacy, medicine, biomedical sciences, health economics, or healthcare management
Analytical, detail‑oriented, and policy‑focused learners
Motivated for specialist roles in pharmaceutical companies, health insurance organizations, government agencies, hospital management, or academia

Course Learning Outcomes

Principles of Pharmacoeconomics

Explain core concepts of pharmacoeconomics, including cost-effectiveness, cost-utility, and cost-benefit analysis
Analyse the economic impact of pharmaceutical interventions in healthcare
Apply pharmacoeconomic principles to evaluate therapeutic options
Assess healthcare costs in relation to clinical outcomes
Critically appraise published pharmacoeconomic studies

Health Technology Assessment (HTA)

Evaluate healthcare interventions using clinical, economic, and social evidence
Conduct systematic reviews to support health technology assessments
Apply HTA methodologies to inform policy and funding decisions
Interpret HTA reports for evidence-based decision-making
Assess the cost-effectiveness and clinical value of new and existing therapies

Budget Impact and Resource Allocation

Analyse the financial impact of pharmaceutical interventions on healthcare budgets
Apply resource allocation models to optimise healthcare spending
Develop strategies for cost containment and efficient use of healthcare resources
Evaluate the economic sustainability of healthcare programmes
Support decision-making in budget planning and healthcare policy

Advanced Economic Modelling

Construct and apply economic models such as decision trees and Markov models
Interpret model outputs to inform healthcare and pharmaceutical decisions
Apply sensitivity analysis to assess model robustness
Evaluate complex scenarios using advanced modelling techniques
Integrate clinical, economic, and statistical data for decision support

Research Methodologies and Evidence-Based Pharmacoeconomics

Design and implement research projects in pharmacoeconomics
Critically evaluate scientific literature and evidence
Apply statistical and analytical methods to research data
Use evidence-based approaches to inform policy and practice
Demonstrate professional and ethical conduct in research activities

Policy, Governance, and Pharmaceutical Strategy

Apply pharmacoeconomic evidence to healthcare policy development
Analyse governance frameworks in pharmaceutical and healthcare systems
Develop strategic initiatives for sustainable healthcare interventions
Evaluate the impact of policy decisions on clinical and economic outcomes
Lead projects that integrate economic analysis into pharmaceutical strategy

Frequently Asked Questions (FAQs)

You will learn cost‑effectiveness analysis, health technology assessment (HTA), budget impact modeling, and outcome measurement, enabling you to evaluate the economic value of medicines and healthcare interventions.

It prepares graduates for specialist roles in pharmaceutical companies, health insurance organizations, government agencies, hospital management, and academia, where pharmacoeconomic expertise is increasingly in demand.

Yes. It supports advancement into senior, specialist, and academic positions by demonstrating mastery of economic evaluation methods and healthcare policy analysis.

The diploma is aligned with postgraduate standards and valued across global healthcare systems, ensuring international career mobility.

It focuses exclusively on pharmacoeconomics, blending pharmaceutical science with health economics and policy, preparing graduates to shape healthcare systems that are both clinically effective and financially sustainable.